esiRNA coding mouse

The esiRNA technology is a powerful tool for loss of function gene studies. To illustrate the potency of silencing triggers quantitative real time (qRT)-PCR is often used to measure the knock-down rates. The knock-down validation on mRNA level was here performed 24 hours post transfection of esiRNA using qRT-PCR. To be able to assess knock-down rates, the expression levels of the mRNA of interest was compared to cells (HeLa or mouse ES) simultaneously transfected with Renilla Luciferase (negative control).

However, a more valuable measure of the knock-down potency in an RNAi experiment is the reduction in protein level. We therefore also validate the knock-down rates of esiRNAs on protein level using quantitative western blot analysis (Odyssey, Li-COR). The time point for maximum knock-down rate for each protein can vary significantly, as it is depending on factors such as protein-stability, turn-over rate or cell proliferation rates. The knock-down validation on protein level was here performed at 72 hours post transfection of esiRNA in HeLa cells.  To be able to assess knock-down rates, the expression levels of the protein of interest was compared to HeLa cells simultaneously transfected with Renilla Luciferase (negative control). 

Two approaches were used to monitor knock-down at protein level: 1. Specific antibodies for the protein of interest were used for the quantitative western blot analysis. 2. Proteins of interest were GFP-tagged on a bacterial artificial chromosome (BAC) and stably integrated into the genome of HeLa cells, allowing for near physiological expression (Poser I. et al Nat Methods. 2008 May;5(5):409-15). Using a GFP antibody the detection by quantitative western blot analysis of the protein of interest is straightforward.

esiRNA IDGene NameGene DescriptionEnsembl IDRefSeq IDKnock-Down RatePic / PDF
EMU072781Atg12 autophagy-related 12 (yeast)ENSMUSG00000032905NM_02621791%Pic / PDF
EMU052231Park7 Parkinson disease (autosomal recessive, early onset) 7ENSMUSG00000028964NM_02056989%Pic / PDF
EMU014921Parp1 poly (ADP-ribose) polymerase family, member 1ENSMUSG00000026496NM_00741587%Pic / PDF
EMU014271Smad3 MAD homolog 3 (Drosophila)ENSMUSG00000032402NM_01676984%Pic / PDF
EMU047871Akt2  thymoma viral proto-oncogene 2ENSMUSG00000004056

NM_001110208
NM_007434

82%Pic / PDF
EMU001711Lyplal1 lysophospholipase-like 1ENSMUSG00000039246NM_14610682%Pic / PDF
EMU044861Cdt1 chromatin licensing and DNA replication factor 1ENSMUSG00000006585NM_02601481%Pic / PDF
EMU190491Prkaa1 protein kinase, AMP-activated, alpha 1 catalytic subunitENSMUSG0000005069774%Pic / PDF



Smad3 / MAD homolog 3 (Drosophila)

Cdt1 / chromatin licensing and DNA replication factor 1

Atg12 / autophagy-related 12 (yeast)

Park7 / Parkinson disease (autosomal recessive, early onset) 7

Akt2 / thymoma viral proto-oncogene 2

Prkaa1 / protein kinase, AMP-activated, alpha 1 catalytic subunit

Parp1 / poly (ADP-ribose) polymerase family, member 1

Lyplal1 / lysophospholipase-like 1